RxDoctor Payments Data

Marco Ferrara, MD

Colon & Rectal Surgery · Orlando, FLNPI 1083973408

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $25,900 of the $35,553 with a category attached, or 72.8%. Johnson & Johnson accounts for 71.1% of it on its own, with 27 other manufacturers making up the rest. 2025 is the largest year on record at $18,092, more than ten times the $617 reported in 2019.

$35,553in general payments, 2019–2025

Across 98 payments — averaging $362.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$25K
  • Davol Inc.$4K
  • Intuitive Surgical$955
  • Ethicon Endo-surgery Inc.$900
  • Medtronic$714
  • Guard Medical Inc.$471
  • plus $3K from 22 others

What the payments were for

  • Consulting fees$25,90073%
  • Speaking & faculty fees$4,16012%
  • Travel & lodging$190%
  • Food & beverage$5,45515%
  • Gifts$200%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$35,553 in reported general payments places this provider in the 80th percentile of 157 colon & rectal surgery providers in Florida.

See all colon & rectal surgery providers in Florida

Medicare billing

Part B allowed, 2024
$99,491
Medicare patients
138
Services billed
461

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Neomycin Sulfate48$296
Metronidazole49$85
Oxycodone Hcl16$29

Paid to pharmacies, not to this prescriber.

Other colon & rectal surgery in Orlando

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →